hyaluronoglucosaminidase has been researched along with melphalan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kjems, E; Mansa, B; Videbaek, A | 1 |
| Bernhardt, G; Buschauer, A; Muckenschnabel, I; Spruss, T | 1 |
2 other study(ies) available for hyaluronoglucosaminidase and melphalan
| Article | Year |
|---|---|
A human IgA-myeloma protein with anti-streptococcal hyaluronidase (ASH) activity.
Topics: Antibodies, Bacterial; Binding Sites, Antibody; Bone Marrow; Bone Marrow Cells; Female; Humans; Hyaluronoglucosaminidase; Immunodiffusion; Immunoelectrophoresis; Immunoglobulin A; Immunoglobulin Fab Fragments; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Prednisone; Saliva | 1973 |
Hyaluronidase pretreatment produces selective melphalan enrichment in malignant melanoma implanted in nude mice.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Division; Cell Transplantation; Chromatography, High Pressure Liquid; Drug Synergism; Drug Therapy, Combination; Humans; Hyaluronoglucosaminidase; Injections, Intraperitoneal; Injections, Subcutaneous; Melanoma, Experimental; Melphalan; Mice; Mice, Nude; Neoplasm Transplantation; Specific Pathogen-Free Organisms; Tissue Distribution; Tumor Cells, Cultured | 1996 |